Rundu Shares released its 2026 interim report, with net profit attributable to the parent company of 40.751 million yuan, an increase of 76.9441 million yuan compared with the same period last year, achieving a turnaround from loss to profit. The company's total operating revenue was 709 million yuan, up 29.34 percent year on year. Net cash inflow from operating activities was 72.7134 million yuan, up 669.59 percent year on year. The company's latest asset-liability ratio was 46.71 percent, gross margin was 43.87 percent, return on equity was 3.78 percent, and diluted earnings per share was 0.12 yuan.
Zhuhai Rundu Pharmaceutical Co Ltd Class ACompany swung to profit with net profit of 40.751 million yuan, revenue up 29.34%.